BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:REQUEST X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Time (US & Canada) BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20191018T194445Z DESCRIPTION:From Two Days to Four Hours: How the AmplideX® PCR/CE SMN1/2 P lus Kit Provides SMN1 and SMN2 Copy Number Information and More…\n\n \n\ nPresented by:\nVivianna van Deerlin\, MD\, PhD\, University of Pennsylvan ia\n\nSpinal muscular atrophy (SMA) results from the homozygous loss of SM N1\, and its severity is inversely correlated with the number of SMN2 copi es. Sequence similarities between these two genes has challenged assay dev elopment and current on-market solutions have a multi-day workflow. In thi s workshop\, we review how the AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) pro vides SMN1 and SMN2 copy number in a simple\, scalable\, and streamlined w orkflow in less than four hours. In the same reaction\, the assay also det ects variants associated with gene duplication as well as milder disease p henotypes.\n\n\n\n\n\nMap of the workshop rooms for more info.\n\n\n DTEND;TZID="Eastern Time (US & Canada)":20191106T125000 DTSTAMP:20191017T173252Z DTSTART;TZID="Eastern Time (US & Canada)":20191106T120000 LAST-MODIFIED:20191018T194445Z LOCATION:Rm 338 - Baltimore Convention Center ORGANIZER;CN="Erin Calver":mailto:ecalver@asuragen.com PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Asuragen Corporate Workshop - SMN1_2 Plus TRANSP:OPAQUE UID:28044C23-5D2B-4D58-B62D-C87A53AFB415 X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\n

From Two Days to Four Hours: How the AmplideX® PCR/CE SMN1/2 Plus Kit Provides SMN1 and SMN2 Copy Num ber Information and More…

\n\n

 \;\n

\n\n

Presented by:\n\n
Vivianna van Deerlin\, MD\, PhD\, University of Pennsylvania\n

\n\n

Spinal muscular atrophy (SMA) results from the homozygous loss o f SMN1\, and its severity is inversely correlated with the number of SMN2 copies. Sequence similarities between these two genes has challenged assay development and current on-market solutions have a multi-day workflow. In this workshop\, we review how the AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) provides SMN1 and SMN2 copy number in a simple\, scalable\, and streamlin ed workflow in less than four hours. In the same reaction\, the assay also detects variants associated with gene duplication as well as milder disea se phenotypes.

\n
\n
\n
\n
\n\n

Map o f the workshop rooms for more info.\n

\n
\n\n\n X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR